These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16361590)

  • 1. Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study.
    Ramió-Torrentà L; Sastre-Garriga J; Ingle GT; Davies GR; Ameen V; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):40-5. PubMed ID: 16361590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study.
    Dehmeshki J; Chard DT; Leary SM; Watt HC; Silver NC; Tofts PS; Thompson AJ; Miller DH
    J Neurol; 2003 Jan; 250(1):67-74. PubMed ID: 12527995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.
    Khaleeli Z; Sastre-Garriga J; Ciccarelli O; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1076-82. PubMed ID: 17287235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis.
    Davies GR; Ramió-Torrentà L; Hadjiprocopis A; Chard DT; Griffin CM; Rashid W; Barker GJ; Kapoor R; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):998-1002. PubMed ID: 15201359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
    Griffin CM; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH
    J Neurol; 2002 Feb; 249(2):193-9. PubMed ID: 11985386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.
    Davies GR; Altmann DR; Hadjiprocopis A; Rashid W; Chard DT; Griffin CM; Tofts PS; Barker GJ; Kapoor R; Thompson AJ; Miller DH
    J Neurol; 2005 Sep; 252(9):1037-44. PubMed ID: 15834645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.
    Tur C; Khaleeli Z; Ciccarelli O; Altmann DR; Cercignani M; Miller DH; Thompson AJ
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):423-8. PubMed ID: 20974648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis.
    Manfredonia F; Ciccarelli O; Khaleeli Z; Tozer DJ; Sastre-Garriga J; Miller DH; Thompson AJ
    Arch Neurol; 2007 Mar; 64(3):411-5. PubMed ID: 17353385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
    Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
    Rovaris M; Judica E; Sastre-Garriga J; Rovira A; Sormani MP; Benedetti B; Korteweg T; De Stefano N; Khaleeli Z; Montalban X; Barkhof F; Miller DH; Polman C; Thompson AJ; Filippi M
    Mult Scler; 2008 May; 14(4):455-64. PubMed ID: 18208869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.
    Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):311-7. PubMed ID: 11181851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis.
    Hayton T; Furby J; Smith KJ; Altmann DR; Brenner R; Chataway J; Hughes RA; Hunter K; Tozer DJ; Miller DH; Kapoor R
    J Neurol; 2009 Mar; 256(3):427-35. PubMed ID: 19271108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities.
    Traboulsee A; Dehmeshki J; Peters KR; Griffin CM; Brex PA; Silver N; Ciccarrelli O; Chard DT; Barker GJ; Thompson AJ; Miller DH
    Mult Scler; 2003 Dec; 9(6):566-73. PubMed ID: 14664468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Iannucci G; Dichgans M; Rovaris M; Brüning R; Gasser T; Giacomotti L; Yousry TA; Filippi M
    Stroke; 2001 Mar; 32(3):643-8. PubMed ID: 11239180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.
    Fernando KT; Tozer DJ; Miszkiel KA; Gordon RM; Swanton JK; Dalton CM; Barker GJ; Plant GT; Thompson AJ; Miller DH
    Brain; 2005 Dec; 128(Pt 12):2911-25. PubMed ID: 16219673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis.
    Hayton T; Furby J; Smith KJ; Altmann DR; Brenner R; Chataway J; Hunter K; Tozer DJ; Miller DH; Kapoor R
    J Neurol; 2012 Feb; 259(2):237-45. PubMed ID: 21863390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis.
    Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; McLean MA; Miller DH; Thompson AJ
    Arch Neurol; 2005 Apr; 62(4):569-73. PubMed ID: 15824254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.
    Hayton T; Furby J; Smith KJ; Altmann DR; Brenner R; Chataway J; Hunter K; Tozer DJ; Miller DH; Kapoor R
    J Neurol; 2012 Mar; 259(3):505-14. PubMed ID: 21904901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study.
    Schmierer K; Altmann DR; Kassim N; Kitzler H; Kerskens CM; Doege CA; Aktas O; Lünemann JD; Miller DH; Zipp F; Villringer A
    Mult Scler; 2004 Apr; 10(2):182-7. PubMed ID: 15124765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis.
    Griffin CM; Chard DT; Ciccarelli O; Kapoor B; Barker GJ; Thompson AI; Miller DH
    Mult Scler; 2001 Oct; 7(5):290-7. PubMed ID: 11724444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.